Lobbying client · LD-2 disclosures
Shire Pharmaceuticals
Massachusetts
18 filings from 3 registrants · 2008–2017 · latest filed Jan 22, 2018
Reported on its behalf
$360K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$360K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medicare/Medicaid
MMM
10 filings
$170K on those filings
Medical/Disease Research/Clinical Labs
MED
5 filings
$140K on those filings
Health Issues
HCR
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- David Joseph Farber King & Spalding LLP11 filingsthrough 2017
- Michael Werner The Werner Group6 filingsthrough 2009
- Kym Howarth Kilbourne Kym H. Kilbourne3 filingsthrough 2014
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: shire-pharmaceuticals.